+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biosurgery Market based by Product Type, By Application, By Source, Regional Outlook - Global Forecast up to 2030- Product Image
Biosurgery Market based by Product Type, By Application, By Source, Regional Outlook - Global Forecast up to 2030- Product Image
Sale

Biosurgery Market based by Product Type, By Application, By Source, Regional Outlook - Global Forecast up to 2030

  • PDF Icon

    Report

  • 146 Pages
  • July 2024
  • Region: Global
  • IHR Insights
  • ID: 5985266
UP TO OFF until Dec 31st 2024
10% Free customization
Description Jump to:
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Through 2032, the hemostatic agents product segment is expected to have significant growth. This can be attributed to the expanding number of surgical procedures performed, the rise in trauma patients, and the growing focus on efficient hemostatic therapies. The increasing frequency of surgical procedures is driving up demand for sophisticated and effective hemostatic agents. ongoing research and development aimed at improving hemostatic drugs' effectiveness.

The cardiovascular surgery section of the biosurgery industry is expected to grow at a significant compound annual growth rate (CAGR) between 2024 and 2030. The improvement in biosurgery products can be ascribed to technological advancements, the rising incidence of cardiovascular disorders, and the growing need for sophisticated surgical solutions. Furthermore, the widespread use of biosurgery solutions in cardiovascular surgeries is a result of increased knowledge about the advantages of biosurgery in cardiovascular procedures.

The market for biosurgery in North America is expected to grow rapidly between 2024 and 2032 as a result of the rise in surgical operations, improvements in medical technology, and rising rates of chronic illness. The region's product appeal is also being boosted by the well-established healthcare system and the growing knowledge of healthcare professionals regarding the advantages of biosurgery. In addition, the regional market expansion will be bolstered by the advantageous reimbursement policies and the high rate of adoption of innovative surgical procedures.

Biosurgery Market based on Application:

  • Neuro And Spine Surgery
  • Orthopedic Surgery
  • General Surgery
  • Cardiovascular And Thoracic Surgery
  • Analog Imaging

Biosurgery Market based on Source:

  • Biologics Products
  • Synthetic Products

Biosurgery Market based on Product Type:

  • Bone Graft Substitutes
  • Hemostatic And Surgical Sealant
  • Mesh
  • Anti Adhesive Agents

Biosurgery Market based on Geography:

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific (RoAPAC)
  • Latin America (LATAM)
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East and Africa (MEA)
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the biosurgery market. The primary sources from the demand side include medical practitioners and hospital managers.

This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and Company house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global biosurgery market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market.

Biosurgery products are becoming more widely used in emerging nations, particularly those in the Asia Pacific, Latin America, the Middle East, and Africa. Players in the biosurgery market should expect to see considerable development prospects in the upcoming years from nations like China, India, and Brazil. This is due to the fact that the markets in these nations are distinguished by a sizable patient base for target indications (such as gynecological, orthopedic, cardiovascular, and general/abdominal disorders), as well as by rapidly developing healthcare infrastructure, growing healthcare expenditure, rising medical tourism, and growing health awareness. In the past few decades, Malaysia and India have become major medical tourism destinations. This is due to the fact that these developing nations' medical procedure costs are much lower than those of industrialized nations like the US, Germany, France, and the UK. Furthermore, government organizations in a number of Middle Eastern and Asia Pacific nations are launching programs to bolster their individual healthcare systems, which is offering biosurgery product producers in developing nations substantial expansion prospects.

Because of the intense competition among the current companies, the biosurgery market is very competitive when it comes to pricing. The majority of the products in this sector are expensive. A significant portion of the intended patient population cannot afford these products due to their high cost and the difficult reimbursement environment they face in developing nations. In emerging nations, traditional surgical techniques including sutures and ligature-based treatments are preferred over biosurgery products because of their high cost. Furthermore, the biosurgery items that are now on the market are poorly stocked, complex reconstitutes. As a result, there is a rising demand for reasonably priced goods that are manageable and have longer shelf lives.
  • This report illustrates the most vital attributes of the Biosurgery Market, which are driving and providing opportunities.
  • This research gives an in-depth analysis of the Biosurgery Market growth on the basis of several segments in the market.
  • This report presents the predictions of the past and present trends of the Biosurgery Market.
  • This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Biosurgery Market.

Table of Contents

1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Application: Market Size & Analysis
5.1. Overview
5.2. Neuro And Spine Surgery
5.3. Orthopedic Surgery
5.4. General Surgery
5.5. Cardiovascular And Thoracic Surgery
5.6. Analog Imaging
6. Source: Market Size & Analysis
6.1. Overview
6.2. Biologics Products
6.3. Synthetic Products
7. Product Type: Market Size & Analysis
7.1. Overview
7.2. Bone Graft Substitutes
7.3. Hemostatic And Surgical Sealant
7.4. Mesh
7.5. Anti-Adhesive Agents
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America (U.S., Mexico, Canada)
8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
8.5. Latin America (Brazil, Argentina)
8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. JOHNSON & JOHNSON
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. BAXTER INTERNATIONAL INC.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. MEDTRONIC PLC
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. BECTON, DICKINSON & CO.
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. B. BRAUN MELSUNGEN AG
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. STRYKER CORP.
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. INTEGRA LIFESCIENCES HOLDINGS CORP.
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. CSL LTD.
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. HEMOSTASIS L.L.C.
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. PFIZER INC.
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. Analyst Opinion
12. Annexure
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations
List of Tables
Table 1. Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 2. Biosurgery Market Value for Neuro and Spine Surgery, by Geography, 2021-2030 (USD Billion)
Table 3. Biosurgery Market Value for Orthopedic Surgery, by Geography, 2021-2030 (USD Billion)
Table 4. Biosurgery Market Value for General Surgery, by Geography, 2021-2030 (USD Billion)
Table 5. Biosurgery Market Value for Cardiovascular and Thoracic Surgery, by Geography, 2021-2030 (USD Billion)
Table 6. Biosurgery Market Value for Analog Imaging, by Geography, 2021-2030 (USD Billion)
Table 7. Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 8. Biosurgery Market Value for Biologics Products, 2021-2030 (USD Billion)
Table 9. Biosurgery Market Value for Synthetic Products, by Geography, 2021-2030 (USD Billion)
Table 10. Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 11. Biosurgery Market Value for Bone Graft Substitutes, 2021-2030 (USD Billion)
Table 12. Biosurgery Market Value for Hemostatic and Surgical Sealant, by Geography, 2021-2030 (USD Billion)
Table 13. Biosurgery Market Value for Mesh, by Geography, 2021-2030 (USD Billion)
Table 14. Biosurgery Market Value for Anti Adhesive Agents, by Geography, 2021-2030 (USD Billion)
Table 15. North America Biosurgery Market Value, by Country, 2021-2030 (USD Billion)
Table 16. North America Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 17. North America Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 18. North America Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 19. U.S Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 20. U.S Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 21. U.S Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 22. Canada Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 23. Canada Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 24. Canada Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 25. Mexico Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 26. Mexico Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 27. Mexico Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 28. Europe Biosurgery Market Value, by Country, 2021-2030 (USD Billion)
Table 29. Europe Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 30. Europe Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 31. Europe Biosurgery Market Value, End Use Industries, 2021-2030 (USD Billion)
Table 32. Germany Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 33. Germany Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 34. Germany Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 35. U.K Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 36. U.K Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 37. U.K Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 38. France Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 39. France Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 40. France Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 41. Italy Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 42. Italy Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 43. Italy Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 44. Spain Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 45. Spain Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 46. Spain Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 47. Roe Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 48. Roe Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 49. Roe Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 50. Asia-Pacific Biosurgery Market Value, by Country, 2021-2030 (USD Billion)
Table 51. Asia-Pacific Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 52. Asia-Pacific Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 53. Asia-Pacific Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 54. China Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 55. China Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 56. China Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 57. India Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 58. India Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 59. India Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 60. Japan Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 61. Japan Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 62. Japan Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 63. Rest of APAC Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 64. Rest of APAC Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 65. Rest of APAC Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 66. Latin America Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 67. Latin America Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 68. Latin America Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 69. Brazil Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 70. Brazil Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 71. Brazil Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 72. Argentina Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 73. Argentina Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 74. Argentina Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 75. Middle East and Africa Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 76. Middle East and Africa Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 77. Middle East and Africa Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 78. Saudi Arabia Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 79. Saudi Arabia Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 80. Saudi Arabia Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 81. Uae Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 82. Uae Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 83. Uae Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 84. Rest of Middle East and Africa Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Table 85. Rest of Middle East and Africa Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Table 86. Rest of Middle East and Africa Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Table 87. Johnson & Johnson: Financials
Table 88. Johnson & Johnson: Products & Services
Table 89. Johnson & Johnson: Recent Developments
Table 90. Baxter International Inc.: Financials
Table 91. Baxter International Inc.: Products & Services
Table 92. Baxter International Inc.: Recent Developments
Table 93. Medtronic plc: Financials
Table 94. Medtronic plc: Products & Services
Table 95. Medtronic plc: Recent Developments
Table 96. Becton, Dickinson & Co.: Financials
Table 97. Becton, Dickinson & Co.: Products & Services
Table 98. Becton, Dickinson & Co.: Recent Developments
Table 99. B. Braun Melsungen Ag: Financials
Table 100. B. Braun Melsungen Ag: Products & Services
Table 101. B. Braun Melsungen Ag: Recent Developments
Table 102. Stryker Corp.: Financials
Table 103. Stryker Corp.: Products & Services
Table 104. Stryker Corp.: Recent Developments
Table 105. Integra Lifesciences Holdings Corp.: Financials
Table 106. Integra Lifesciences Holdings Corp.: Products & Services
Table 107. Integra Lifesciences Holdings Corp.: Developments
Table 108. Csl Ltd.: Financials
Table 109. Csl Ltd.: Products & Services
Table 110. Csl Ltd.: Recent Developments
Table 111. Hemostasis L.L.C.: Financials
Table 112. Hemostasis L.L.C.: Products & Services
Table 113. Hemostasis L.L.C.: Recent Developments
Table 114. Pfizer Inc.: Financials
Table 115. Pfizer Inc.: Products & Services
Table 116. Pfizer Inc.: Recent Developments
List of Figures
Chart. 1. Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 2. Biosurgery Market Value for Neuro and Spine Surgery, by Geography, 2021-2030 (USD Billion)
Chart. 3. Biosurgery Market Value for Orthopedic Surgery, by Geography, 2021-2030 (USD Billion)
Chart. 4. Biosurgery Market Value for General Surgery, by Geography, 2021-2030 (USD Billion)
Chart. 5. Biosurgery Market Value for Cardiovascular and Thoracic Surgery, by Geography, 2021-2030 (USD Billion)
Chart. 6. Biosurgery Market Value for Analog Imaging, by Geography, 2021-2030 (USD Billion)
Chart. 7. Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 8. Biosurgery Market Value for Biologics Products, 2021-2030 (USD Billion)
Chart. 9. Biosurgery Market Value for Synthetic Products, by Geography, 2021-2030 (USD Billion)
Chart. 10. Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 11. Biosurgery Market Value for Bone Graft Substitutes, 2021-2030 (USD Billion)
Chart. 12. Biosurgery Market Value for Hemostatic and Surgical Sealant, by Geography, 2021-2030 (USD Billion)
Chart. 13. Biosurgery Market Value for Mesh, by Geography, 2021-2030 (USD Billion)
Chart. 14. Biosurgery Market Value for Anti Adhesive Agents, by Geography, 2021-2030 (USD Billion)
Chart. 15. North America Biosurgery Market Value, by Country, 2021-2030 (USD Billion)
Chart. 16. North America Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 17. North America Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 18. North America Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 19. U.S Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 20. U.S Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 21. U.S Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 22. Canada Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 23. Canada Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 24. Canada Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 25. Mexico Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 26. Mexico Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 27. Mexico Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 28. Europe Biosurgery Market Value, by Country, 2021-2030 (USD Billion)
Chart. 29. Europe Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 30. Europe Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 31. Europe Biosurgery Market Value, End Use Industries, 2021-2030 (USD Billion)
Chart. 32. Germany Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 33. Germany Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 34. Germany Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 35. U.K Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 36. U.K Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 37. U.K Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 38. France Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 39. France Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 40. France Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 41. Italy Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 42. Italy Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 43. Italy Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 44. Spain Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 45. Spain Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 46. Spain Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 47. Roe Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 48. Roe Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 49. Roe Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 50. Asia-Pacific Biosurgery Market Value, by Country, 2021-2030 (USD Billion)
Chart. 51. Asia-Pacific Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 52. Asia-Pacific Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 53. Asia-Pacific Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 54. China Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 55. China Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 56. China Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 57. India Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 58. India Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 59. India Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 60. Japan Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 61. Japan Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 62. Japan Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 63. Rest of APAC Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 64. Rest of APAC Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 65. Rest of APAC Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 66. Latin America Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 67. Latin America Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 68. Latin America Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 69. Brazil Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 70. Brazil Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 71. Brazil Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 72. Argentina Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 73. Argentina Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 74. Argentina Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 75. Middle East and Africa Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 76. Middle East and Africa Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 77. Middle East and Africa Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 78. Saudi Arabia Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 79. Saudi Arabia Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 80. Saudi Arabia Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 81. Uae Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 82. Uae Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 83. Uae Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 84. Rest of Middle East and Africa Biosurgery Market Value, by Source, 2021-2030 (USD Billion)
Chart. 85. Rest of Middle East and Africa Biosurgery Market Value, by Application, 2021-2030 (USD Billion)
Chart. 86. Rest of Middle East and Africa Biosurgery Market Value, by Product Type, 2021-2030 (USD Billion)
Chart. 87. Johnson & Johnson: Financials
Chart. 88. Johnson & Johnson: Products & Services
Chart. 89. Johnson & Johnson: Recent Developments
Chart. 90. Baxter International Inc.: Financials
Chart. 91. Baxter International Inc.: Products & Services
Chart. 92. Baxter International Inc.: Recent Developments
Chart. 93. Medtronic plc: Financials
Chart. 94. Medtronic plc: Products & Services
Chart. 95. Medtronic plc: Recent Developments
Chart. 96. Becton, Dickinson & Co.: Financials
Chart. 97. Becton, Dickinson & Co.: Products & Services
Chart. 98. Becton, Dickinson & Co.: Recent Developments
Chart. 99. B. Braun Melsungen Ag: Financials
Chart. 100. B. Braun Melsungen Ag: Products & Services
Chart. 101. B. Braun Melsungen Ag: Recent Developments
Chart. 102. Stryker Corp.: Financials
Chart. 103. Stryker Corp.: Products & Services
Chart. 104. Stryker Corp.: Recent Developments
Chart. 105. Integra Lifesciences Holdings Corp.: Financials
Chart. 106. Integra Lifesciences Holdings Corp.: Products & Services
Chart. 107. Integra Lifesciences Holdings Corp.: Developments
Chart. 108. Csl Ltd.: Financials
Chart. 109. Csl Ltd.: Products & Services
Chart. 110. Csl Ltd.: Recent Developments
Chart. 111. Hemostasis L.L.C.: Financials
Chart. 112. Hemostasis L.L.C.: Products & Services
Chart. 113. Hemostasis L.L.C.: Recent Developments
Chart. 114. Pfizer Inc.: Financials
Chart. 115. Pfizer Inc.: Products & Services
Chart. 116. Pfizer Inc.: Recent Developments

Companies Mentioned

  • JOHNSON & JOHNSON
  • BAXTER INTERNATIONAL INC.
  • MEDTRONIC PLC
  • BECTON, DICKINSON & CO.
  • B. BRAUN MELSUNGEN AG
  • STRYKER CORP.
  • INTEGRA LIFESCIENCES HOLDINGS CORP.
  • CSL LTD.
  • HEMOSTASIS L.L.C.
  • PFIZER INC.,

Related Topics

Related Reports

Biosurgery - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Biosurgery - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Biosurgery Market by Product, Source, Application, End-Users - Global Forecast 2025-2030 - Product Image

Biosurgery Market by Product, Source, Application, End-Users - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Biosurgery Market Size, Share and Trends Analysis Report by Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments), Application (General Surgery, Orthopedic Surgery), and Region 2024-2030 - Product Image

Biosurgery Market Size, Share and Trends Analysis Report by Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments), Application (General Surgery, Orthopedic Surgery), and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Biosurgery Global Market Report 2024 - Product Image

Biosurgery Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Biosurgery Market Report and Forecast 2024-2032 - Product Image

Biosurgery Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.